Literature DB >> 29038946

Cognitive and behavioral disorders in Parkinson's disease: an update. II: behavioral disorders.

Luigi Trojano1,2, Costanza Papagno3,4.   

Abstract

Patients with Parkinson's disease (PD) can experience several behavioral symptoms, such as apathy, agitation, hypersexuality, stereotypic movements, pathological gambling, abuse of antiparkinsonian drugs, and REM sleep behavioral disorders. Psychoses and hallucinations, depression and anxiety disorders, and difficulties in recognizing and experiencing emotions also impair behavior and can cause severe psychosocial problems in patients with PD. Symptoms can be present since early stages of the disease, sometimes even before the appearance of classical motor symptoms, likely in relation to dopamine depletion in basal ganglia and/or to dysfunctions of other neurotrasmitter systems, and others can develop later, in some cases in relation to dopaminergic treatment. In this paper, we review recent literature, with particular attention to the last 5 years, on the main behavioral and emotional disturbances described in PD patients as well as the hypothesized neurofunctional substrate of such impairments. Finally, we provide some suggestions on the most suitable instruments to check and assess PD-associated behavioral defects over time.

Entities:  

Keywords:  Apathy; Behavioral disorders; Depression; Emotional disorders; Parkinson’s disease; Psychosis

Mesh:

Year:  2017        PMID: 29038946     DOI: 10.1007/s10072-017-3155-7

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  77 in total

1.  Prevalence and characteristics of alexithymia in Parkinson's disease.

Authors:  Alberto Costa; Antonella Peppe; Giovanni A Carlesimo; Giovanna Salamone; Carlo Caltagirone
Journal:  Psychosomatics       Date:  2010 Jan-Feb       Impact factor: 2.386

Review 2.  MDS research criteria for prodromal Parkinson's disease.

Authors:  Daniela Berg; Ronald B Postuma; Charles H Adler; Bastiaan R Bloem; Piu Chan; Bruno Dubois; Thomas Gasser; Christopher G Goetz; Glenda Halliday; Lawrence Joseph; Anthony E Lang; Inga Liepelt-Scarfone; Irene Litvan; Kenneth Marek; José Obeso; Wolfgang Oertel; C Warren Olanow; Werner Poewe; Matthew Stern; Günther Deuschl
Journal:  Mov Disord       Date:  2015-10       Impact factor: 10.338

3.  Facial emotion recognition in Parkinson's disease: Association with age and olfaction.

Authors:  S Kalampokini; E Lyros; M Luley; J Schöpe; J Spiegel; J Bürmann; U Dillmann; K Fassbender; M M Unger
Journal:  J Clin Exp Neuropsychol       Date:  2017-06-21       Impact factor: 2.475

4.  Why people see things that are not there: a novel Perception and Attention Deficit model for recurrent complex visual hallucinations.

Authors:  Daniel Collerton; Elaine Perry; Ian McKeith
Journal:  Behav Brain Sci       Date:  2005-12       Impact factor: 12.579

Review 5.  Changes in neural circuitry associated with depression at pre-clinical, pre-motor and early motor phases of Parkinson's disease.

Authors:  Janina Borgonovo; Camilo Allende-Castro; Almudena Laliena; Néstor Guerrero; Hernán Silva; Miguel L Concha
Journal:  Parkinsonism Relat Disord       Date:  2016-11-21       Impact factor: 4.891

6.  Major life events and development of major depression in Parkinson's disease patients.

Authors:  N H Rod; Y Bordelon; A Thompson; E Marcotte; B Ritz
Journal:  Eur J Neurol       Date:  2012-10-30       Impact factor: 6.089

7.  Emotion processing in Parkinson's disease: a three-level study on recognition, representation, and regulation.

Authors:  Ivan Enrici; Mauro Adenzato; Rita B Ardito; Antonia Mitkova; Marco Cavallo; Maurizio Zibetti; Leonardo Lopiano; Lorys Castelli
Journal:  PLoS One       Date:  2015-06-25       Impact factor: 3.240

8.  Degraded Impairment of Emotion Recognition in Parkinson's Disease Extends from Negative to Positive Emotions.

Authors:  Chia-Yao Lin; Yi-Min Tien; Jong-Tsun Huang; Chon-Haw Tsai; Li-Chuan Hsu
Journal:  Behav Neurol       Date:  2016-07-31       Impact factor: 3.342

9.  Anxiety is associated with cognitive impairment in newly-diagnosed Parkinson's disease.

Authors:  Nadeeka N W Dissanayaka; Rachael A Lawson; Alison J Yarnall; Gordon W Duncan; David P Breen; Tien K Khoo; Roger A Barker; David J Burn
Journal:  Parkinsonism Relat Disord       Date:  2017-01-04       Impact factor: 4.891

10.  The default mode network is disrupted in Parkinson's disease with visual hallucinations.

Authors:  Nailin Yao; Richard Shek-Kwan Chang; Charlton Cheung; Shirley Pang; Kui Kai Lau; John Suckling; James B Rowe; Kevin Yu; Henry Ka-Fung Mak; Siew-Eng Chua; Shu Leong Ho; Grainne M McAlonan
Journal:  Hum Brain Mapp       Date:  2014-07-01       Impact factor: 5.038

View more
  16 in total

1.  Frontal lobe metabolic alterations characterizing Parkinson's disease cognitive impairment.

Authors:  Shefali Chaudhary; S Senthil Kumaran; Vinay Goyal; M Kalaivani; Gauri Shanker Kaloiya; Rajesh Sagar; Nalin Mehta; Achal Kumar Srivastava; N R Jagannathan
Journal:  Neurol Sci       Date:  2020-07-29       Impact factor: 3.307

2.  Italian version of the Starkstein Apathy Scale (SAS-I) and a shortened version (SAS-6) to assess "pure apathy" symptoms: normative study on 392 individuals.

Authors:  Elisabetta Garofalo; Alessandro Iavarone; Sergio Chieffi; Michele Carpinelli Mazzi; Nadia Gamboz; Ferdinando Ivano Ambra; Maria Sannino; Filomena Galeone; Sabrina Esposito; Bruno Ronga; Ciro Rosario Ilardi
Journal:  Neurol Sci       Date:  2020-07-29       Impact factor: 3.307

Review 3.  Dementia with Lewy bodies and Parkinson's disease-dementia: current concepts and controversies.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2017-12-08       Impact factor: 3.575

4.  News on the journal Neurological Sciences in 2017.

Authors:  Ilaria Di Donato; Antonio Federico
Journal:  Neurol Sci       Date:  2018-01       Impact factor: 3.307

5.  Non-motor symptoms of Parkinson's disease: dopaminergic basis or not?

Authors:  Chanwoo Kim
Journal:  Neurol Sci       Date:  2019-06-17       Impact factor: 3.307

Review 6.  Deep Brain Stimulation in Parkinson Disease: A Meta-analysis of the Long-term Neuropsychological Outcomes.

Authors:  Madalina Bucur; Costanza Papagno
Journal:  Neuropsychol Rev       Date:  2022-03-23       Impact factor: 6.940

7.  Incidence of sarcopenia and dynapenia according to stage in patients with idiopathic Parkinson's disease.

Authors:  Tamer Yazar; Hülya Olgun Yazar; Emel Zayimoğlu; Soner Çankaya
Journal:  Neurol Sci       Date:  2018-05-12       Impact factor: 3.307

8.  White matter alterations in early Parkinson's disease: role of motor symptom lateralization.

Authors:  Laura Pelizzari; Sonia Di Tella; Maria M Laganà; Niels Bergsland; Federica Rossetto; Raffaello Nemni; Francesca Baglio
Journal:  Neurol Sci       Date:  2019-10-24       Impact factor: 3.307

Review 9.  Insights into the Pathophysiology of Psychiatric Symptoms in Central Nervous System Disorders: Implications for Early and Differential Diagnosis.

Authors:  Giulia Menculini; Elena Chipi; Federico Paolini Paoletti; Lorenzo Gaetani; Pasquale Nigro; Simone Simoni; Andrea Mancini; Nicola Tambasco; Massimiliano Di Filippo; Alfonso Tortorella; Lucilla Parnetti
Journal:  Int J Mol Sci       Date:  2021-04-23       Impact factor: 5.923

Review 10.  Biological and Clinical Implications of Comorbidities in Parkinson's Disease.

Authors:  Jose A Santiago; Virginie Bottero; Judith A Potashkin
Journal:  Front Aging Neurosci       Date:  2017-12-04       Impact factor: 5.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.